Application of fetal stem cells in CKD: Does it promise renal regeneration?

Tuganbekova S., Gaipov A., Saparbayev S., Krivoruchko N., Kuzembayeva K., Shaimardanova G., Rakhimbekova G.

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Introduction and Aims: Progression of glomerulosclerosis is inevitable in glomerular diseases and development of ESRD is relatively rapid than other causes of CKD. Application of stem cell therapy is one of the promising technology to regenerate own renal tissue, although it is very difficult due to complex tissue consisting of renal cells. Stem cells obtained from kidney tissue of fetus might be potentially effective approach to regenerate renal cells.We aimed to study efficacy of fetal renal stem cells in CKD caused by chronic glomerular diseases and determine the progression rate of CKD. Methods: This is a prospective cohort study, which included 17 patients with chronic glomerulonephritis stage 2-4 CKD, who completed three visits during the one year follow-up period. Fetal renal stem cells prepared from the kidney tissue of aborted fetus in 16-18 weeks of gestation. These stem cells cultivated in DMEM media and conserved in glycerin at - 80c. The study group received FRST via IV infusion according to study protocol every 6 months. Routine laboratory renal tests obtained during each visits. Patients were divided in to two groups according to GFR median (above and below 40 ml/min). First group included 8 patients (4 male and 4 female) and second group included 9 patients (4 male and 5 female). GFR decline rate calculated as ml/min/months. Results: All of two groups were comparable for age (39,5+/-14,8 vs 39,44+/-7,89 years), sex, disease duration and other clinical settings. Initial laboratory data and their changes after stem cell therapy are presented in Table 1. During the follow-up period, stable hemoglobin labels observed in both groups. GFR decline rate is presented in Table 2. Slow progression of renal failure observed after first injection of stem cells in first group and after second injection in second group. Conclusions: Treatment with fetal renal stem cells may be beneficial in kidney diseases caused by glomerular origin. Further studies with a large number of patients may help to achieve better results. (Table Presented).
Original languageEnglish
Title of host publicationNephrology Dialysis Transplantation
Place of PublicationS. Tuganbekova, National Scientific Medical Research Center, Internal Medicine, Astana, Kazakhstan
PublisherOxford University Press
Pagesiii157-iii158
ISBN (Print)0931-0509
Publication statusPublished - 2015

Publication series

NameNephrology Dialysis Transplantation
Volume30

Keywords

  • *edetic acid
  • *fetal stem cell
  • *regeneration
  • chronic glomerulonephritis
  • cohort analysis
  • disease duration
  • end stage renal disease
  • female
  • fetus
  • fetus death
  • follow up
  • glomerulopathy
  • glomerulosclerosis
  • glycerol
  • hemoglobin
  • human
  • injection
  • intravenous drug administration
  • kidney cell
  • kidney disease
  • kidney failure
  • kidney parenchyma
  • laboratory
  • male
  • patient
  • pregnancy
  • stem cell
  • stem cell transplantation
  • technology
  • tissues

Fingerprint Dive into the research topics of 'Application of fetal stem cells in CKD: Does it promise renal regeneration?'. Together they form a unique fingerprint.

  • Cite this

    S., T., A., G., S., S., N., K., K., K., G., S., & G., R. (2015). Application of fetal stem cells in CKD: Does it promise renal regeneration? In Nephrology Dialysis Transplantation (pp. iii157-iii158). (Nephrology Dialysis Transplantation; Vol. 30). Oxford University Press.